FA
CVS icon

Faithward Advisors’s CVS Health CVS Stock Holding History

Faithward Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,206
Closed -$421K – 262
2023
Q3 		$421K Buy
6,206
+106
+2% +$7.51K 0.1% 118
2023
Q2 		$457K Sell
6,100
-879
-13% -$62.5K 0.11% 106
2023
Q1 		$481K Buy
6,979
+4
+0.1% +$335 0.11% 112
2022
Q4 		$650K Buy
6,975
+89
+1% +$8.59K 0.14% 85
2022
Q3 		$657K Buy
+6,886
New +$682K 0.16% 78
2020
Q3 		– Sell
-4,194
Closed -$272K – 219
2020
Q2 		$272K Hold
4,194
– – 0.07% 116
2020
Q1 		$249K Hold
4,194
– – 0.07% 138
2019
Q4 		$312K Sell
4,194
-1,383
-25% -$97.1K 0.07% 123
2019
Q3 		$352K Buy
+5,577
New +$330K 0.08% 77

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Faithward Advisors's CVS Position: Q4 2023 in Review

Faithward Advisors sold out of CVS Health (CVS) in Q4 2023, closing a stake of 6,206 shares — an estimated $421K sold.

Faithward Advisors first reported a position in CVS in Q3 2019 and held it in 9 quarters. The position peaked at $657K in Q3 2022. 2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • Faithward Advisors reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
  • Faithward Advisors sold 6,206 CVS Health shares in Q4 2023, an estimated $421K.
  • Faithward Advisors first reported a position in CVS Health in Q3 2019 and held it in 9 quarters.
  • Faithward Advisors's CVS Health position peaked at $657K in Q3 2022.
  • 2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Faithward Advisors's 13F filing for Q4 2023, filed 15 Feb 2024.